Foundation Medicine has a big IDEA—Improving Diagnostics Education and Awareness—and, now, it's handing out a new grant attached to the program. Specifically, the Boston-based precision medicine ...

Pharmaceutical giant Roche Holding will pay $2.4 billion to acquire the remaining shares it doesn’t already own of Foundation Medicine, putting more stake into a future for personalized cancer ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., today announced the launch of its tissue-naïve circulating tumor DNA (ctDNA) monitoring assay, FoundationOne®Monitor, for research use in ...

BOSTON & EL MONTE, Calif.--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline tests, ...

Boca Raton, Fla.-based Cancer Treatment Centers of America and Foundation Medicine are collaborating on an educational campaign to raise awareness regarding the potential of precision medicine.

Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, today announced a partnership with Manifold, the leading artificial intelligence (AI) data ...

BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (PMVP) (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop ...

First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the United States and Japan, setting the standard for high-quality genomic ...